World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
12029
World Ranking
2964
National Ranking
1394

Daniel F. Hoft publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Daniel F. Hoft sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 222 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Daniel F. Hoft D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel F. Hoft sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Daniel F. Hoft is affiliated with Saint Louis University in the United States. Their research primarily spans multiple fields, including Medicine, Immunology and Microbiology, and Biochemistry, Genetics, and Molecular Biology. Within these domains, they have contributed extensively to subfields such as Immunology, Infectious Diseases, Epidemiology, Molecular Biology, and Health.

The main topics covered by Daniel F. Hoft's research include:

  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Influenza Virus Research Studies
  • Tuberculosis Research and Epidemiology
  • Immune responses and vaccinations
  • Immunodeficiency and Autoimmune Disorders
  • Vaccines and immunoinformatics approaches

The scientist has published frequently in several venues. The primary publication venues include:

  • Frontiers in Immunology
  • The Journal of Immunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • Clinical Infectious Diseases

Some recent papers authored by Daniel F. Hoft include:

  • "Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy," 2021, Science Translational Medicine
  • "SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells," 2020, PLoS Pathogens
  • "Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools," 2020, Frontiers in Immunology
  • "Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy," 2020, Journal of Clinical Investigation
  • "NK and NKT cells have distinct properties and functions in cancer," 2021, Oncogene

Frequent coauthors in their work include:

  • Nadine Rouphael
  • Christopher S. Eickhoff
  • Sharon E. Frey
  • Evan J. Anderson
  • Azra Blazevic

Best Publications

  • Tumor Microenvironments Direct the Recruitment and Expansion of Human Th17 Cells

    Xinming Su;Jian Ye;Eddy C. Hsueh;Yanping Zhang

  • Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

    Daniel F. Hoft;Elizabeth Babusis;Shewangizaw Worku;Charles T. Spencer

  • Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection.

    Wei-Jen Chua;Steven M. Truscott;Christopher S. Eickhoff;Azra Blazevic

  • Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.

    Daniel F. Hoft;Robin M. Brown;Stanford T. Roodman

  • TLR8-Mediated Metabolic Control of Human Treg Function: A Mechanistic Target for Cancer Immunotherapy

    Lingyun Li;Xia Liu;Katherine L. Sanders;James L. Edwards

  • Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy.

    Xia Liu;Celine L. Hartman;Lingyun Li;Carolyn J. Albert

  • Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition.

    Xia Liu;Wei Mo;Jian Ye;Lingyun Li

  • Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.

    Kayvon Modjarrad;Leyi Lin;Sarah L George;Sarah L George;Kathryn E Stephenson;Kathryn E Stephenson

  • Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer

    Chunling Ma;Qunyuan Zhang;Jian Ye;Fang Wang;Fang Wang

  • CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome

    Yi Huang;Chunling Ma;Qunyuan Zhang;Jian Ye

  • A New Recombinant Bacille Calmette-Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers

    Daniel F. Hoft;Azra Blazevic;Getahun Abate;Willem A. Hanekom

  • Immune responses to plasmid DNA encoding the hepatitis C virus core protein.

    L. M. Lagging;K. Meyer;D. Hoft;M. Houghton

  • Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.

    Jian Ye;Chunling Ma;Eddy C. Hsueh;Christopher S. Eickhoff

  • Enhancement of Innate and Cell-Mediated Immunity by Antimycobacterial Antibodies

    S. de Vallière;G. Abate;A. Blazevic;R. M. Heuertz

  • SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells.

    Tapas Patra;Keith Meyer;Lizzie Geerling;T. Scott Isbell

  • Human regulatory T cells induce T-lymphocyte senescence

    Jian Ye;Xingxu Huang;Eddy C. Hsueh;Qunyuan Zhang

  • Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity.

    Daniel F. Hoft;Shewangizaw Worku;Beate Kampmann;Christopher C. Whalen

  • Use of Protein Antigens for Early Serological Diagnosis of Leprosy

    Malcolm S. Duthie;Wakako Goto;Greg C. Ireton;Stephen T. Reece

  • TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence

    Jian Ye;Chunling Ma;Eddy C Hsueh;Jie Dou

  • Tuberculosis vaccine development: goals, immunological design, and evaluation.

    Daniel F Hoft

Frequent Co-Authors

Guangyong Peng
Guangyong Peng Saint Louis University
Robert B. Belshe
Robert B. Belshe Saint Louis University
Mark J. Mulligan
Mark J. Mulligan New York University
Jamie Rossjohn
Jamie Rossjohn Monash University
Nadine Rouphael
Nadine Rouphael Emory University
Willem A. Hanekom
Willem A. Hanekom University College London
Ted H. Hansen
Ted H. Hansen Washington University in St. Louis
Ranjit Ray
Ranjit Ray Saint Louis University
Lars Kjer-Nielsen
Lars Kjer-Nielsen University of Melbourne
David P. Fairlie
David P. Fairlie University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, pursuing advanced degrees in nursing, especially Nurse Practitioner programs, offers a promising pathway. Many professionals start with a Family Nurse Practitioner (FNP) background and then pursue acute care certification for fnp to specialize in acute care settings, which aligns well with immunology’s focus on critical and chronic conditions.

Choosing the right program can impact both career trajectory and affordability. Those looking for budget-friendly options might consider the cheapest pmhnp programs, which support advanced practice roles while keeping costs low.

Career growth is also influenced by specialty and geographic location. Nurses with Doctor of Nursing Practice degrees often seek roles that offer competitive compensation, with research into the highest paid dnp specialties providing insight into lucrative fields within healthcare.

For those eager to expedite their studies, enrolling in a nurse practitioner accelerated program can help reduce time to graduation and entry into the workforce, making it an attractive option for career changers or those aiming to specialize quickly.

Best Scientists Citing Daniel F. Hoft

Trending Scientists

Recently Published Articles